Pleural Diseases Therapeutics Market

Future Market Insights

Key Insight

Pleural diseases therapeutics sales will expand through 2036, with chemotherapy holding 58.2% of the treatment segment in 2026. The market was valued at USD 5.65 billion in 2025 and is expected to be worth USD 11.06 billion by 2036, creating an incremental opportunity of USD 5.06 billion between 2026 and 2036.

April 22, 2026

Anurag Sharma

291 Pages

Cite this Report

Pleural Diseases Therapeutics Market

https://www.futuremarketinsights.com/reports/pleural-diseases-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

BlackRock
Becton
BioInvent International
Bristol-Myers Squibb
Dickinson
Medtronic plc
Novocure
Roche (Genentech)
Rocket Medical plc
Smiths Medical
Veracyte Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Pleural Diseases Therapeutics Market

Key Players

Similar Industry Reports